ZG16 impacts gut microbiota-associated intestinal inflammation and pulmonary mucosal function through bacterial metabolites
International Immunopharmacology · 2024-11 · 141 · 112995
DOI: 10.1016/j.intimp.2024.112995 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-11. Verfasst von Xinping Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Key Laboratory of Animal Resistance Biology, College of Life Sciences, Shandong Normal University, Jinan 250014, PR China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Intestinal Mucosa, Mice, Inbred C57BL, Mice, Knockout. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Shanghai Municipality Science and Technology Commission, National Natural Science Foundation of China, Shandong Province Natural Science Foundation.
Abstract (Originalsprache)
Zymogen granule 16 (ZG16) is a secretory glycoprotein found in zymogen granules, which also plays an important role in colorectal inflammation and cancer. Herein, a ZG16 gene knock-out (ZG16-/-) mouse line was established and we found that ZG16 deletion damaged the intestinal mucosal barrier and gut microbiota, which resulted in low-level inflammation and further promoted the development of ulcerative colitis and inflammation-related colorectal cancer. Meanwhile, a metabolomics analysis on mouse feces showed that the metabolites significantly differed between ZG16-/- and WT mice, which were important mediators of host-microbiota communication and may impact the pulmonary inflammation of mice. Indeed, ZG16-/- mice showed more severe inflammation in a bronchial asthma model. Taken together, the results demonstrate that ZG16 plays a pivotal role in inhibiting inflammation and regulating immune responses in colorectum and lung of experimental animals, which may provide a better understanding of the underlying mechanism of human inflammatory diseases associated with ZG16.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong Provincial Key Laboratory of Animal Resistance Biology, College of Life Sciences, Shandong Normal University, Jinan 250014, PR China.
- The Center for Microbes, Development, and Health, CAS Key Laboratory of Molecular Virology & Immunology, Shanghai Institute of Immunity and Infection, University of Chinese Academy of Sciences, Shanghai 200031, PR China…
- Shandong Provincial Key Laboratory of Animal Resistance Biology, College of Life Sciences, Shandong Normal University, Jinan 250014, PR China. Electronic address: yanggw@sdnu.edu.cn.
- Shandong Provincial Key Laboratory of Animal Resistance Biology, College of Life Sciences, Shandong Normal University, Jinan 250014, PR China; The Center for Microbes, Development, and Health, CAS Key Laboratory of Mole…
Förderung
- Shanghai Municipality Science and Technology Commission
- National Natural Science Foundation of China
- Shandong Province Natural Science Foundation
Zitieren
APA
Chen, X., Chen, Y., Zhang, Y., Zhang, Y., Wang, Y., Li, Y., Sun, Y., Meng, G., Yang, G., & Li, H. (2024). ZG16 impacts gut microbiota-associated intestinal inflammation and pulmonary mucosal function through bacterial metabolites. International Immunopharmacology, 141, 112995. https://doi.org/10.1016/j.intimp.2024.112995
Vancouver
Chen X, Chen Y, Zhang Y, Zhang Y, Wang Y, Li Y, et al. ZG16 impacts gut microbiota-associated intestinal inflammation and pulmonary mucosal function through bacterial metabolites. International Immunopharmacology. 2024;141:112995. doi:10.1016/j.intimp.2024.112995
BibTeX
@article{Chen2024,
author = {Chen, Xinping and Chen, Yixin and Zhang, Ying and Zhang, Yonghuan and Wang, Yao and Li, Yingjia and Sun, Yaqi and Meng, Guangxun and Yang, Guiwen and Li, Hua},
title = {ZG16 impacts gut microbiota-associated intestinal inflammation and pulmonary mucosal function through bacterial metabolites},
journal = {International Immunopharmacology},
year = {2024},
volume = {141},
pages = {112995},
doi = {10.1016/j.intimp.2024.112995}
}
EUVIMED